Results 51 to 60 of about 7,515,540 (162)
Human Vaccines & Immunotherapeutics, 2017 One hundred and ninety eight females aged 12–15 y were enrolled in an observer-blinded randomized trial to assess the immunogenicity and reactogenicity of the tetravalent HPV vaccine Gardasil® (group 2), in comparison to the bivalent HPV vaccine ...
Tao Haskins-Coulter +3 more
doaj +1 more source
Study on the elimination of leukocyte interference with apheresis platelet RNA assay
Zhongguo shuxue zazhiObjective To investigate the effect of a small amount of leukocyte mixed in platelets on platelet RNA related study, and to further propose a method to remove leukocyte contamination.
LIN Fengqiu, LI Xiaofeng, LI Jianping
doaj +1 more source
Zhongguo shuxue zazhi, 2023 Objective To monitor the positive rates of IgM and IgG antibodies and the changes in S/CO values over time in voluntary blood donors infected with SARS-CoV-2 after recovery, in order to provide theoretical basis and data support for ensuring clinical ...
Hui ZHANG +6 more
doaj +1 more source
Pathogen‐inactivated blood products for pediatric patients: blood safety, patient safety, or both?
Transfusion, 2018 T he past decades have witnessed a dramatic improvement in blood product safety due to a multifaceted approach including blood donor screening, sensitive infectious disease testing, and good manufacturing practice.
C. Jacquot, M. Delaney
semanticscholar +1 more source
SARS-CoV-2 epidemic and blood safety
Zhongguo shuxue zazhi, 2022 The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen that causes novel coronavirus pneumonia. The SARS-CoV-2 mainly transmits through respiratory tract.
Yongshui FU
doaj +1 more source
Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk
Transfusion Medicine Reviews, 2017 While the transfusion-transmission (TT) risk associated with the major transfusion-relevant viruses such as HIV is now very low, during the last 20 years there has been a growing awareness of the threat to blood safety from emerging infectious diseases ...
P. Kiely +5 more
semanticscholar +1 more source
Blood Safety Status in WHO African Region Countries: Lessons Learnt from Mauritius
Journal of Blood Transfusion, 2017 In 2001, the WHO Office for Africa adopted a strategy for blood safety defining four targets. This paper describes the progress made by Mauritius in the implementation of this strategy.
A. Loua +4 more
semanticscholar +1 more source
Emerging Infectious Agents and Blood Safety in Latin America
Frontiers in Medicine, 2018 Historically, emerging infectious agents have been an important driving force toward the enhancement of blood safety, illustrated by the sharp reduction in the transmission of infectious agents by blood transfusion after human immunodeficiency virus (HIV)
J. Levi
semanticscholar +1 more source
Scientific Reports, 2017 p38α plays an important role in many inflammatory diseases, such as skin inflammation, endotoxic shock and arthritis. Ubiquitination is a vital posttranslational modification of proteins and plays a crucial regulatory role in inflammatory cells.
Qingjun Liu +3 more
doaj +1 more source
Evaluation of a NATSpert test developed for low-resource countries for enhancing blood safety
Global Journal of Transfusion Medicine, 2020 Background: NATSpert ID TripleH Detection test is a qualitative multiplex real time PCR test for simultaneous screening of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus type 1/2 in donated blood.
Minal Dakhave Bhosale, Shefali Desai
doaj +1 more source